Larvol Delta - 177LuLuDWJ155-FML539-a-novel-HER2targeting-radioligand-therapy-for-the-treatment-of-HER2low-and-HER2positive-breast-cancer-BC-and-HER2expressing-nonsmall-cell-lung-cancer-NSCLC

FML539 - Novartis

https://cm.eortc.org/cmPortal/Searchable/ena2026/config/Normal#!abstractdetails/0000998050

Danielle Park

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next